Vestmark Advisory Solutions’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.13M | Buy |
615,294
+321,894
| +110% | +$3.73M | 0.1% | 150 |
|
|
2025
Q1 | $2.56M | Sell |
293,400
-2,139
| -0.7% | -$18.7K | 0.07% | 296 |
|
|
2024
Q4 | $5.02M | Buy |
295,539
+47,357
| +19% | +$804K | 0.17% | 121 |
|
|
2024
Q3 | $5.6M | Buy |
248,182
+59,855
| +32% | +$1.35M | 0.21% | 99 |
|
|
2024
Q2 | $3.66M | Buy |
188,327
+32,284
| +21% | +$628K | 0.15% | 147 |
|
|
2024
Q1 | $5.86M | Buy |
156,043
+78,634
| +102% | +$2.95M | 0.25% | 89 |
|
|
2023
Q4 | $4.33M | Buy |
+77,409
| New | +$4.33M | 0.22% | 114 |
|
|
2022
Q3 | – | Sell |
-9,913
| Closed | -$448K | – | 878 |
|
|
2022
Q2 | $448K | Sell |
9,913
-753
| -7% | -$34K | 0.03% | 567 |
|
|
2022
Q1 | $811K | Buy |
10,666
+5,070
| +91% | +$386K | 0.05% | 414 |
|
|
2021
Q4 | $833K | Buy |
+5,596
| New | +$833K | 0.05% | 402 |
|